Antidepressant medications (SSRIs, SNRIs and others): what it is & what the evidence says

How it works

Different classes act on serotonin, norepinephrine and other systems. Benefits usually build over several weeks; OCD often needs higher doses and longer trials than depression.

What the evidence says, use by use

Evidence is specific to the condition, population and—for devices—the exact product. One label never covers everything.

Depression: Treating moderate to severe depression

Established

Who was studied / who it’s for: Adults; selected medicines for adolescentsWhat this label means: Strong research and/or authoritative clinical guidelines support this specific use.

Guidelines include antidepressants as a treatment option, often combined with psychotherapy.

Sources: NICE (UK) · NIMH

Anxiety: Treating generalized anxiety and panic disorder

Established

Who was studied / who it’s for: AdultsWhat this label means: Strong research and/or authoritative clinical guidelines support this specific use.

SSRIs (and some SNRIs) are recommended medication options for GAD and panic disorder.

Sources: NICE (UK)

OCD: Treating OCD

Established

Who was studied / who it’s for: Children, teens and adultsWhat this label means: Strong research and/or authoritative clinical guidelines support this specific use.

SSRIs are recommended for OCD, often combined with ERP, especially when symptoms are moderate to severe.

Sources: NICE (UK) · NIMH

Autism: Treating core autism features

Not recommended for this use

Who was studied / who it’s for: Autistic children and adultsWhat this label means: Authoritative guidance or regulators advise against this use, usually because of no benefit, real risk, or both.

UK guidance advises against antidepressants for core features of autism—though they may be appropriate for co-occurring depression, anxiety or OCD.

Sources: NICE (UK) · NICE (UK)

Who usually provides it

Psychiatrists, primary care clinicians and other prescribers.

Cautions & things to know

Antidepressants carry an FDA boxed warning about suicidal thoughts in people under 25—close monitoring early on matters.
Stopping suddenly can cause discontinuation symptoms; changes should be planned with the prescriber.
In bipolar disorder, antidepressants need specialist oversight.

Questions for a clinician

Conversation prompts, not a treatment plan.

Why this medicine for this condition?
How long before we judge whether it helps?
What side effects should we watch for, and when should we call?

Educational, not medical advice. NeuroCoach is an educational and care-navigation resource, not a medical provider. Information about medications, supplements, therapies, devices, clinical trials and community experiences is provided for education and exploration and is not a recommendation, diagnosis or treatment plan. Evidence varies substantially among interventions. Decisions about medical or mental-health treatment should be made with an appropriately qualified healthcare professional. Do not start, stop or change medication, supplements or treatment based solely on information found here.

Sources

Sources checked October 5, 2026. Links support this page; they don’t imply endorsement of NeuroCoach.